Pharma & Healthcare
Global Radiopharmaceuticals for Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 21, 25
- ID: 558314
- Pages: 175
- Figures: 176
- Views: 10
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Radiopharmaceuticals for Diagnosis market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Atom High-tech Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
Guangdong Xi'ai Pharmaceutical Co., Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
Chengdu Yunke Pharmaceutical Co., Ltd.
Shanghai Atom Kexing Pharmaceutical Co., Ltd.
Shenzhen Larven Bioengineering Technology Co., Ltd.
Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
Beijing Zhibo High-tech Biotechnology Co., Ltd.
Tianjin Said Biopharmaceutical Co., Ltd.
Chengdu Zhonghe Gaotong Isotope Co., Ltd.
Chengdu Xinke Pharmaceutical Co., Ltd.
Jubilant Radiopharma
PDRadiopharma Inc.
GE Healthcare Ltd
DOE IP
RadioMedix, Inc.
Lantheus
Segment by Type
Technetium [99mTc] Dithiodithiocarbamate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Pentetate
Strontium [89Sr] Chloride
Iodine [125I] Sealed Seed Source
Sodium Iodide [131I]
Other
Segment by Application
Hospital
Clinic
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Radiopharmaceuticals for Diagnosis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Radiopharmaceuticals for Diagnosis market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Atom High-tech Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
Guangdong Xi'ai Pharmaceutical Co., Ltd.
Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
Chengdu Yunke Pharmaceutical Co., Ltd.
Shanghai Atom Kexing Pharmaceutical Co., Ltd.
Shenzhen Larven Bioengineering Technology Co., Ltd.
Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
Beijing Zhibo High-tech Biotechnology Co., Ltd.
Tianjin Said Biopharmaceutical Co., Ltd.
Chengdu Zhonghe Gaotong Isotope Co., Ltd.
Chengdu Xinke Pharmaceutical Co., Ltd.
Jubilant Radiopharma
PDRadiopharma Inc.
GE Healthcare Ltd
DOE IP
RadioMedix, Inc.
Lantheus
Segment by Type
Technetium [99mTc] Dithiodithiocarbamate
Technetium [99mTc] Polymerized Albumin
Technetium [99mTc] Pentetate
Strontium [89Sr] Chloride
Iodine [125I] Sealed Seed Source
Sodium Iodide [131I]
Other
Segment by Application
Hospital
Clinic
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Radiopharmaceuticals for Diagnosis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Radiopharmaceuticals for Diagnosis: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Radiopharmaceuticals for Diagnosis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Technetium 99mTc Dithiodithiocarbamate
1.2.3 Technetium 99mTc Polymerized Albumin
1.2.4 Technetium 99mTc Pentetate
1.2.5 Strontium 89Sr Chloride
1.2.6 Iodine 125I Sealed Seed Source
1.2.7 Sodium Iodide 131I
1.2.8 Other
1.3 Market Segmentation by Application
1.3.1 Global Radiopharmaceuticals for Diagnosis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals for Diagnosis Revenue Estimates and Forecasts 2020-2031
2.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts 2020-2031
2.4 Global Radiopharmaceuticals for Diagnosis Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Radiopharmaceuticals for Diagnosis Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Technetium 99mTc Dithiodithiocarbamate Market Size by Manufacturers
3.5.2 Technetium 99mTc Polymerized Albumin Market Size by Manufacturers
3.5.3 Technetium 99mTc Pentetate Market Size by Manufacturers
3.5.4 Strontium 89Sr Chloride Market Size by Manufacturers
3.5.5 Iodine 125I Sealed Seed Source Market Size by Manufacturers
3.5.6 Sodium Iodide 131I Market Size by Manufacturers
3.5.7 Other Market Size by Manufacturers
3.6 Global Radiopharmaceuticals for Diagnosis Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Radiopharmaceuticals for Diagnosis Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Radiopharmaceuticals for Diagnosis Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Radiopharmaceuticals for Diagnosis Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
6.4 North America Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Radiopharmaceuticals for Diagnosis Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
7.4 Europe Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
9.4 Central and South America Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Radiopharmaceuticals for Diagnosis Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Atom High-tech Co., Ltd.
11.1.1 Atom High-tech Co., Ltd. Corporation Information
11.1.2 Atom High-tech Co., Ltd. Business Overview
11.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.1.6 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.1.7 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.1.8 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.1.9 Atom High-tech Co., Ltd. Recent Developments
11.2 Shanghai Xinke Pharmaceutical Co., Ltd.
11.2.1 Shanghai Xinke Pharmaceutical Co., Ltd. Corporation Information
11.2.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
11.2.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.2.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.2.6 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.2.7 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.2.8 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.2.9 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
11.3 Guangdong Xi'ai Pharmaceutical Co., Ltd.
11.3.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
11.3.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.3.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.3.6 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.3.7 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.3.8 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.3.9 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
11.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
11.4.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Corporation Information
11.4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
11.4.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.4.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.4.6 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.4.7 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.4.8 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis SWOT Analysis
11.4.9 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
11.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
11.5.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
11.5.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.5.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.5.6 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.5.7 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.5.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.5.9 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
11.6 Chengdu Yunke Pharmaceutical Co., Ltd.
11.6.1 Chengdu Yunke Pharmaceutical Co., Ltd. Corporation Information
11.6.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
11.6.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.6.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
11.7 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
11.7.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
11.7.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.7.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
11.8 Shenzhen Larven Bioengineering Technology Co., Ltd.
11.8.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Corporation Information
11.8.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
11.8.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.8.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
11.9 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
11.9.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Corporation Information
11.9.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
11.9.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.9.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
11.10 Beijing Zhibo High-tech Biotechnology Co., Ltd.
11.10.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Corporation Information
11.10.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
11.10.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.10.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
11.11 Tianjin Said Biopharmaceutical Co., Ltd.
11.11.1 Tianjin Said Biopharmaceutical Co., Ltd. Corporation Information
11.11.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
11.11.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.11.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
11.12 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
11.12.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Corporation Information
11.12.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
11.12.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.12.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
11.13 Chengdu Xinke Pharmaceutical Co., Ltd.
11.13.1 Chengdu Xinke Pharmaceutical Co., Ltd. Corporation Information
11.13.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
11.13.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.13.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
11.14 Jubilant Radiopharma
11.14.1 Jubilant Radiopharma Corporation Information
11.14.2 Jubilant Radiopharma Business Overview
11.14.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.14.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Jubilant Radiopharma Recent Developments
11.15 PDRadiopharma Inc.
11.15.1 PDRadiopharma Inc. Corporation Information
11.15.2 PDRadiopharma Inc. Business Overview
11.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 PDRadiopharma Inc. Recent Developments
11.16 GE Healthcare Ltd
11.16.1 GE Healthcare Ltd Corporation Information
11.16.2 GE Healthcare Ltd Business Overview
11.16.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.16.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 GE Healthcare Ltd Recent Developments
11.17 DOE IP
11.17.1 DOE IP Corporation Information
11.17.2 DOE IP Business Overview
11.17.3 DOE IP Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.17.4 DOE IP Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 DOE IP Recent Developments
11.18 RadioMedix, Inc.
11.18.1 RadioMedix, Inc. Corporation Information
11.18.2 RadioMedix, Inc. Business Overview
11.18.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.18.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 RadioMedix, Inc. Recent Developments
11.19 Lantheus
11.19.1 Lantheus Corporation Information
11.19.2 Lantheus Business Overview
11.19.3 Lantheus Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.19.4 Lantheus Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Lantheus Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Radiopharmaceuticals for Diagnosis Industry Chain
12.2 Radiopharmaceuticals for Diagnosis Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Radiopharmaceuticals for Diagnosis Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Radiopharmaceuticals for Diagnosis Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Radiopharmaceuticals for Diagnosis Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Radiopharmaceuticals for Diagnosis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Radiopharmaceuticals for Diagnosis: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Radiopharmaceuticals for Diagnosis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Technetium 99mTc Dithiodithiocarbamate
1.2.3 Technetium 99mTc Polymerized Albumin
1.2.4 Technetium 99mTc Pentetate
1.2.5 Strontium 89Sr Chloride
1.2.6 Iodine 125I Sealed Seed Source
1.2.7 Sodium Iodide 131I
1.2.8 Other
1.3 Market Segmentation by Application
1.3.1 Global Radiopharmaceuticals for Diagnosis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals for Diagnosis Revenue Estimates and Forecasts 2020-2031
2.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts 2020-2031
2.4 Global Radiopharmaceuticals for Diagnosis Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Radiopharmaceuticals for Diagnosis Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Technetium 99mTc Dithiodithiocarbamate Market Size by Manufacturers
3.5.2 Technetium 99mTc Polymerized Albumin Market Size by Manufacturers
3.5.3 Technetium 99mTc Pentetate Market Size by Manufacturers
3.5.4 Strontium 89Sr Chloride Market Size by Manufacturers
3.5.5 Iodine 125I Sealed Seed Source Market Size by Manufacturers
3.5.6 Sodium Iodide 131I Market Size by Manufacturers
3.5.7 Other Market Size by Manufacturers
3.6 Global Radiopharmaceuticals for Diagnosis Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Radiopharmaceuticals for Diagnosis Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Radiopharmaceuticals for Diagnosis Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Radiopharmaceuticals for Diagnosis Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
6.4 North America Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Radiopharmaceuticals for Diagnosis Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
7.4 Europe Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Radiopharmaceuticals for Diagnosis Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
9.4 Central and South America Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Radiopharmaceuticals for Diagnosis Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Radiopharmaceuticals for Diagnosis Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Radiopharmaceuticals for Diagnosis Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Atom High-tech Co., Ltd.
11.1.1 Atom High-tech Co., Ltd. Corporation Information
11.1.2 Atom High-tech Co., Ltd. Business Overview
11.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.1.6 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.1.7 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.1.8 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.1.9 Atom High-tech Co., Ltd. Recent Developments
11.2 Shanghai Xinke Pharmaceutical Co., Ltd.
11.2.1 Shanghai Xinke Pharmaceutical Co., Ltd. Corporation Information
11.2.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
11.2.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.2.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.2.6 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.2.7 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.2.8 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.2.9 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
11.3 Guangdong Xi'ai Pharmaceutical Co., Ltd.
11.3.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
11.3.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.3.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.3.6 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.3.7 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.3.8 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.3.9 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
11.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
11.4.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Corporation Information
11.4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
11.4.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.4.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.4.6 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.4.7 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.4.8 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis SWOT Analysis
11.4.9 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
11.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
11.5.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
11.5.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.5.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Product in 2024
11.5.6 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Application in 2024
11.5.7 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales by Geographic Area in 2024
11.5.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
11.5.9 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
11.6 Chengdu Yunke Pharmaceutical Co., Ltd.
11.6.1 Chengdu Yunke Pharmaceutical Co., Ltd. Corporation Information
11.6.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
11.6.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.6.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
11.7 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
11.7.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
11.7.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.7.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
11.8 Shenzhen Larven Bioengineering Technology Co., Ltd.
11.8.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Corporation Information
11.8.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
11.8.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.8.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
11.9 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
11.9.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Corporation Information
11.9.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
11.9.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.9.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
11.10 Beijing Zhibo High-tech Biotechnology Co., Ltd.
11.10.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Corporation Information
11.10.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
11.10.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.10.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
11.11 Tianjin Said Biopharmaceutical Co., Ltd.
11.11.1 Tianjin Said Biopharmaceutical Co., Ltd. Corporation Information
11.11.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
11.11.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.11.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
11.12 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
11.12.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Corporation Information
11.12.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
11.12.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.12.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
11.13 Chengdu Xinke Pharmaceutical Co., Ltd.
11.13.1 Chengdu Xinke Pharmaceutical Co., Ltd. Corporation Information
11.13.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
11.13.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.13.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
11.14 Jubilant Radiopharma
11.14.1 Jubilant Radiopharma Corporation Information
11.14.2 Jubilant Radiopharma Business Overview
11.14.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.14.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Jubilant Radiopharma Recent Developments
11.15 PDRadiopharma Inc.
11.15.1 PDRadiopharma Inc. Corporation Information
11.15.2 PDRadiopharma Inc. Business Overview
11.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 PDRadiopharma Inc. Recent Developments
11.16 GE Healthcare Ltd
11.16.1 GE Healthcare Ltd Corporation Information
11.16.2 GE Healthcare Ltd Business Overview
11.16.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.16.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 GE Healthcare Ltd Recent Developments
11.17 DOE IP
11.17.1 DOE IP Corporation Information
11.17.2 DOE IP Business Overview
11.17.3 DOE IP Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.17.4 DOE IP Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 DOE IP Recent Developments
11.18 RadioMedix, Inc.
11.18.1 RadioMedix, Inc. Corporation Information
11.18.2 RadioMedix, Inc. Business Overview
11.18.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.18.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 RadioMedix, Inc. Recent Developments
11.19 Lantheus
11.19.1 Lantheus Corporation Information
11.19.2 Lantheus Business Overview
11.19.3 Lantheus Radiopharmaceuticals for Diagnosis Product Models, Descriptions and Specifications
11.19.4 Lantheus Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Lantheus Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Radiopharmaceuticals for Diagnosis Industry Chain
12.2 Radiopharmaceuticals for Diagnosis Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Radiopharmaceuticals for Diagnosis Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Radiopharmaceuticals for Diagnosis Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Radiopharmaceuticals for Diagnosis Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Radiopharmaceuticals for Diagnosis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Radiopharmaceuticals for Diagnosis Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K Units)
Table 8. Global Radiopharmaceuticals for Diagnosis Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Radiopharmaceuticals for Diagnosis Sales Share by Manufacturers (2020-2025)
Table 12. Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Radiopharmaceuticals for Diagnosis by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Diagnosis as of 2024)
Table 16. Global Radiopharmaceuticals for Diagnosis Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Radiopharmaceuticals for Diagnosis Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Radiopharmaceuticals for Diagnosis Manufacturing Base and Headquarters
Table 19. Global Radiopharmaceuticals for Diagnosis Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Radiopharmaceuticals for Diagnosis Sales by Type (2020-2025) & (K Units)
Table 23. Global Radiopharmaceuticals for Diagnosis Sales by Type (2026-2031) & (K Units)
Table 24. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Radiopharmaceuticals for Diagnosis ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Radiopharmaceuticals for Diagnosis Sales by Application (2020-2025) & (K Units)
Table 29. Global Radiopharmaceuticals for Diagnosis Sales by Application (2026-2031) & (K Units)
Table 30. Radiopharmaceuticals for Diagnosis High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Radiopharmaceuticals for Diagnosis ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Radiopharmaceuticals for Diagnosis Growth Accelerators and Market Barriers
Table 37. North America Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Radiopharmaceuticals for Diagnosis Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Radiopharmaceuticals for Diagnosis Growth Accelerators and Market Barriers
Table 40. Europe Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Radiopharmaceuticals for Diagnosis Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Radiopharmaceuticals for Diagnosis Growth Accelerators and Market Barriers
Table 45. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Radiopharmaceuticals for Diagnosis Investment Opportunities and Key Challenges
Table 47. Central and South America Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Radiopharmaceuticals for Diagnosis Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Atom High-tech Co., Ltd. Corporation Information
Table 51. Atom High-tech Co., Ltd. Description and Major Businesses
Table 52. Atom High-tech Co., Ltd. Product Models, Descriptions and Specifications
Table 53. Atom High-tech Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Atom High-tech Co., Ltd. Sales Value Proportion by Product in 2024
Table 55. Atom High-tech Co., Ltd. Sales Value Proportion by Application in 2024
Table 56. Atom High-tech Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 57. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 58. Atom High-tech Co., Ltd. Recent Developments
Table 59. Shanghai Xinke Pharmaceutical Co., Ltd. Corporation Information
Table 60. Shanghai Xinke Pharmaceutical Co., Ltd. Description and Major Businesses
Table 61. Shanghai Xinke Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 62. Shanghai Xinke Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Shanghai Xinke Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 64. Shanghai Xinke Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 65. Shanghai Xinke Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 66. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 67. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
Table 68. Guangdong Xi'ai Pharmaceutical Co., Ltd. Corporation Information
Table 69. Guangdong Xi'ai Pharmaceutical Co., Ltd. Description and Major Businesses
Table 70. Guangdong Xi'ai Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 71. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 73. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 74. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 75. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 76. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
Table 77. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Corporation Information
Table 78. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Description and Major Businesses
Table 79. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Product Models, Descriptions and Specifications
Table 80. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales Value Proportion by Product in 2024
Table 82. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales Value Proportion by Application in 2024
Table 83. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales Value Proportion by Geographic Area in 2024
Table 84. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 85. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
Table 86. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Corporation Information
Table 87. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Description and Major Businesses
Table 88. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 89. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 91. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 92. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 93. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 94. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
Table 95. Chengdu Yunke Pharmaceutical Co., Ltd. Corporation Information
Table 96. Chengdu Yunke Pharmaceutical Co., Ltd. Description and Major Businesses
Table 97. Chengdu Yunke Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 98. Chengdu Yunke Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
Table 100. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Corporation Information
Table 101. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Description and Major Businesses
Table 102. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 103. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
Table 105. Shenzhen Larven Bioengineering Technology Co., Ltd. Corporation Information
Table 106. Shenzhen Larven Bioengineering Technology Co., Ltd. Description and Major Businesses
Table 107. Shenzhen Larven Bioengineering Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 108. Shenzhen Larven Bioengineering Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
Table 110. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Corporation Information
Table 111. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Description and Major Businesses
Table 112. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 113. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
Table 115. Beijing Zhibo High-tech Biotechnology Co., Ltd. Corporation Information
Table 116. Beijing Zhibo High-tech Biotechnology Co., Ltd. Description and Major Businesses
Table 117. Beijing Zhibo High-tech Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 118. Beijing Zhibo High-tech Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
Table 120. Tianjin Said Biopharmaceutical Co., Ltd. Corporation Information
Table 121. Tianjin Said Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 122. Tianjin Said Biopharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 123. Tianjin Said Biopharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
Table 125. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Corporation Information
Table 126. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Description and Major Businesses
Table 127. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Product Models, Descriptions and Specifications
Table 128. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
Table 130. Chengdu Xinke Pharmaceutical Co., Ltd. Corporation Information
Table 131. Chengdu Xinke Pharmaceutical Co., Ltd. Description and Major Businesses
Table 132. Chengdu Xinke Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 133. Chengdu Xinke Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
Table 135. Jubilant Radiopharma Corporation Information
Table 136. Jubilant Radiopharma Description and Major Businesses
Table 137. Jubilant Radiopharma Product Models, Descriptions and Specifications
Table 138. Jubilant Radiopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Jubilant Radiopharma Recent Developments
Table 140. PDRadiopharma Inc. Corporation Information
Table 141. PDRadiopharma Inc. Description and Major Businesses
Table 142. PDRadiopharma Inc. Product Models, Descriptions and Specifications
Table 143. PDRadiopharma Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. PDRadiopharma Inc. Recent Developments
Table 145. GE Healthcare Ltd Corporation Information
Table 146. GE Healthcare Ltd Description and Major Businesses
Table 147. GE Healthcare Ltd Product Models, Descriptions and Specifications
Table 148. GE Healthcare Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. GE Healthcare Ltd Recent Developments
Table 150. DOE IP Corporation Information
Table 151. DOE IP Description and Major Businesses
Table 152. DOE IP Product Models, Descriptions and Specifications
Table 153. DOE IP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. DOE IP Recent Developments
Table 155. RadioMedix, Inc. Corporation Information
Table 156. RadioMedix, Inc. Description and Major Businesses
Table 157. RadioMedix, Inc. Product Models, Descriptions and Specifications
Table 158. RadioMedix, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. RadioMedix, Inc. Recent Developments
Table 160. Lantheus Corporation Information
Table 161. Lantheus Description and Major Businesses
Table 162. Lantheus Product Models, Descriptions and Specifications
Table 163. Lantheus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Lantheus Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals for Diagnosis Product Picture
Figure 2. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Technetium 99mTc Dithiodithiocarbamate Product Picture
Figure 4. Technetium 99mTc Polymerized Albumin Product Picture
Figure 5. Technetium 99mTc Pentetate Product Picture
Figure 6. Strontium 89Sr Chloride Product Picture
Figure 7. Iodine 125I Sealed Seed Source Product Picture
Figure 8. Sodium Iodide 131I Product Picture
Figure 9. Other Product Picture
Figure 10. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Radiopharmaceuticals for Diagnosis Report Years Considered
Figure 15. Global Radiopharmaceuticals for Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 17. Global Radiopharmaceuticals for Diagnosis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2020-2031)
Figure 19. Global Radiopharmaceuticals for Diagnosis Sales (2020-2031) & (K Units)
Figure 20. Global Radiopharmaceuticals for Diagnosis Sales (CAGR) by Region (2020-2031) (K Units)
Figure 21. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2020-2031)
Figure 22. Top 5 and Top 10 Manufacturers Radiopharmaceuticals for Diagnosis Sales Volume Market Share in 2024
Figure 23. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Ranking (2024)
Figure 24. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 25. Technetium 99mTc Dithiodithiocarbamate Revenue Market Share by Manufacturer in 2024
Figure 26. Technetium 99mTc Polymerized Albumin Revenue Market Share by Manufacturer in 2024
Figure 27. Technetium 99mTc Pentetate Revenue Market Share by Manufacturer in 2024
Figure 28. Strontium 89Sr Chloride Revenue Market Share by Manufacturer in 2024
Figure 29. Iodine 125I Sealed Seed Source Revenue Market Share by Manufacturer in 2024
Figure 30. Sodium Iodide 131I Revenue Market Share by Manufacturer in 2024
Figure 31. Other Revenue Market Share by Manufacturer in 2024
Figure 32. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2020-2031)
Figure 33. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2020-2031)
Figure 34. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2020-2031)
Figure 35. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2020-2031)
Figure 36. North America Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 37. North America Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 39. North America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2020- 2031)
Figure 40. North America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 42. North America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 47. Europe Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 49. Europe Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2020-2031)
Figure 50. Europe Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 52. Europe Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 54. France Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 59. Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2020- 2031)
Figure 62. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 64. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 69. India Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 71. Central and South America Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2021-2031)
Figure 74. Central and South America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 76. Central and South America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 80. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2021-2031)
Figure 83. South America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 85. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 90. Radiopharmaceuticals for Diagnosis Industry Chain Mapping
Figure 91. Regional Radiopharmaceuticals for Diagnosis Manufacturing Base Distribution (%)
Figure 92. Global Radiopharmaceuticals for Diagnosis Production Market Share by Region (2020-2031)
Figure 93. Radiopharmaceuticals for Diagnosis Production Process
Figure 94. Regional Radiopharmaceuticals for Diagnosis Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Table 1. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Radiopharmaceuticals for Diagnosis Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Radiopharmaceuticals for Diagnosis Sales by Region (2020-2025) & (K Units)
Table 8. Global Radiopharmaceuticals for Diagnosis Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Radiopharmaceuticals for Diagnosis Sales Share by Manufacturers (2020-2025)
Table 12. Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Radiopharmaceuticals for Diagnosis by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Diagnosis as of 2024)
Table 16. Global Radiopharmaceuticals for Diagnosis Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Radiopharmaceuticals for Diagnosis Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Radiopharmaceuticals for Diagnosis Manufacturing Base and Headquarters
Table 19. Global Radiopharmaceuticals for Diagnosis Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Radiopharmaceuticals for Diagnosis Sales by Type (2020-2025) & (K Units)
Table 23. Global Radiopharmaceuticals for Diagnosis Sales by Type (2026-2031) & (K Units)
Table 24. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Radiopharmaceuticals for Diagnosis ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Radiopharmaceuticals for Diagnosis Sales by Application (2020-2025) & (K Units)
Table 29. Global Radiopharmaceuticals for Diagnosis Sales by Application (2026-2031) & (K Units)
Table 30. Radiopharmaceuticals for Diagnosis High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Radiopharmaceuticals for Diagnosis ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Radiopharmaceuticals for Diagnosis Growth Accelerators and Market Barriers
Table 37. North America Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Radiopharmaceuticals for Diagnosis Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Radiopharmaceuticals for Diagnosis Growth Accelerators and Market Barriers
Table 40. Europe Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Radiopharmaceuticals for Diagnosis Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Radiopharmaceuticals for Diagnosis Growth Accelerators and Market Barriers
Table 45. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Radiopharmaceuticals for Diagnosis Investment Opportunities and Key Challenges
Table 47. Central and South America Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Radiopharmaceuticals for Diagnosis Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Atom High-tech Co., Ltd. Corporation Information
Table 51. Atom High-tech Co., Ltd. Description and Major Businesses
Table 52. Atom High-tech Co., Ltd. Product Models, Descriptions and Specifications
Table 53. Atom High-tech Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Atom High-tech Co., Ltd. Sales Value Proportion by Product in 2024
Table 55. Atom High-tech Co., Ltd. Sales Value Proportion by Application in 2024
Table 56. Atom High-tech Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 57. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 58. Atom High-tech Co., Ltd. Recent Developments
Table 59. Shanghai Xinke Pharmaceutical Co., Ltd. Corporation Information
Table 60. Shanghai Xinke Pharmaceutical Co., Ltd. Description and Major Businesses
Table 61. Shanghai Xinke Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 62. Shanghai Xinke Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Shanghai Xinke Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 64. Shanghai Xinke Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 65. Shanghai Xinke Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 66. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 67. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
Table 68. Guangdong Xi'ai Pharmaceutical Co., Ltd. Corporation Information
Table 69. Guangdong Xi'ai Pharmaceutical Co., Ltd. Description and Major Businesses
Table 70. Guangdong Xi'ai Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 71. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 73. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 74. Guangdong Xi'ai Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 75. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 76. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
Table 77. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Corporation Information
Table 78. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Description and Major Businesses
Table 79. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Product Models, Descriptions and Specifications
Table 80. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales Value Proportion by Product in 2024
Table 82. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales Value Proportion by Application in 2024
Table 83. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Sales Value Proportion by Geographic Area in 2024
Table 84. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 85. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
Table 86. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Corporation Information
Table 87. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Description and Major Businesses
Table 88. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 89. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
Table 91. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
Table 92. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 93. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis SWOT Analysis
Table 94. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
Table 95. Chengdu Yunke Pharmaceutical Co., Ltd. Corporation Information
Table 96. Chengdu Yunke Pharmaceutical Co., Ltd. Description and Major Businesses
Table 97. Chengdu Yunke Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 98. Chengdu Yunke Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
Table 100. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Corporation Information
Table 101. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Description and Major Businesses
Table 102. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 103. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
Table 105. Shenzhen Larven Bioengineering Technology Co., Ltd. Corporation Information
Table 106. Shenzhen Larven Bioengineering Technology Co., Ltd. Description and Major Businesses
Table 107. Shenzhen Larven Bioengineering Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 108. Shenzhen Larven Bioengineering Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
Table 110. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Corporation Information
Table 111. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Description and Major Businesses
Table 112. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 113. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
Table 115. Beijing Zhibo High-tech Biotechnology Co., Ltd. Corporation Information
Table 116. Beijing Zhibo High-tech Biotechnology Co., Ltd. Description and Major Businesses
Table 117. Beijing Zhibo High-tech Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 118. Beijing Zhibo High-tech Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
Table 120. Tianjin Said Biopharmaceutical Co., Ltd. Corporation Information
Table 121. Tianjin Said Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 122. Tianjin Said Biopharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 123. Tianjin Said Biopharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
Table 125. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Corporation Information
Table 126. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Description and Major Businesses
Table 127. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Product Models, Descriptions and Specifications
Table 128. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
Table 130. Chengdu Xinke Pharmaceutical Co., Ltd. Corporation Information
Table 131. Chengdu Xinke Pharmaceutical Co., Ltd. Description and Major Businesses
Table 132. Chengdu Xinke Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
Table 133. Chengdu Xinke Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
Table 135. Jubilant Radiopharma Corporation Information
Table 136. Jubilant Radiopharma Description and Major Businesses
Table 137. Jubilant Radiopharma Product Models, Descriptions and Specifications
Table 138. Jubilant Radiopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Jubilant Radiopharma Recent Developments
Table 140. PDRadiopharma Inc. Corporation Information
Table 141. PDRadiopharma Inc. Description and Major Businesses
Table 142. PDRadiopharma Inc. Product Models, Descriptions and Specifications
Table 143. PDRadiopharma Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. PDRadiopharma Inc. Recent Developments
Table 145. GE Healthcare Ltd Corporation Information
Table 146. GE Healthcare Ltd Description and Major Businesses
Table 147. GE Healthcare Ltd Product Models, Descriptions and Specifications
Table 148. GE Healthcare Ltd Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. GE Healthcare Ltd Recent Developments
Table 150. DOE IP Corporation Information
Table 151. DOE IP Description and Major Businesses
Table 152. DOE IP Product Models, Descriptions and Specifications
Table 153. DOE IP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. DOE IP Recent Developments
Table 155. RadioMedix, Inc. Corporation Information
Table 156. RadioMedix, Inc. Description and Major Businesses
Table 157. RadioMedix, Inc. Product Models, Descriptions and Specifications
Table 158. RadioMedix, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. RadioMedix, Inc. Recent Developments
Table 160. Lantheus Corporation Information
Table 161. Lantheus Description and Major Businesses
Table 162. Lantheus Product Models, Descriptions and Specifications
Table 163. Lantheus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Lantheus Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals for Diagnosis Product Picture
Figure 2. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Technetium 99mTc Dithiodithiocarbamate Product Picture
Figure 4. Technetium 99mTc Polymerized Albumin Product Picture
Figure 5. Technetium 99mTc Pentetate Product Picture
Figure 6. Strontium 89Sr Chloride Product Picture
Figure 7. Iodine 125I Sealed Seed Source Product Picture
Figure 8. Sodium Iodide 131I Product Picture
Figure 9. Other Product Picture
Figure 10. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Radiopharmaceuticals for Diagnosis Report Years Considered
Figure 15. Global Radiopharmaceuticals for Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 17. Global Radiopharmaceuticals for Diagnosis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2020-2031)
Figure 19. Global Radiopharmaceuticals for Diagnosis Sales (2020-2031) & (K Units)
Figure 20. Global Radiopharmaceuticals for Diagnosis Sales (CAGR) by Region (2020-2031) (K Units)
Figure 21. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2020-2031)
Figure 22. Top 5 and Top 10 Manufacturers Radiopharmaceuticals for Diagnosis Sales Volume Market Share in 2024
Figure 23. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Ranking (2024)
Figure 24. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 25. Technetium 99mTc Dithiodithiocarbamate Revenue Market Share by Manufacturer in 2024
Figure 26. Technetium 99mTc Polymerized Albumin Revenue Market Share by Manufacturer in 2024
Figure 27. Technetium 99mTc Pentetate Revenue Market Share by Manufacturer in 2024
Figure 28. Strontium 89Sr Chloride Revenue Market Share by Manufacturer in 2024
Figure 29. Iodine 125I Sealed Seed Source Revenue Market Share by Manufacturer in 2024
Figure 30. Sodium Iodide 131I Revenue Market Share by Manufacturer in 2024
Figure 31. Other Revenue Market Share by Manufacturer in 2024
Figure 32. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2020-2031)
Figure 33. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2020-2031)
Figure 34. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2020-2031)
Figure 35. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2020-2031)
Figure 36. North America Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 37. North America Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 39. North America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2020- 2031)
Figure 40. North America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 42. North America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 47. Europe Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 49. Europe Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2020-2031)
Figure 50. Europe Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 52. Europe Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 54. France Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 59. Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2020- 2031)
Figure 62. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 64. Asia-Pacific Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 69. India Radiopharmaceuticals for Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 71. Central and South America Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2021-2031)
Figure 74. Central and South America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 76. Central and South America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Radiopharmaceuticals for Diagnosis Sales YoY (2020-2031) & (K Units)
Figure 80. Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Type (2021-2031)
Figure 83. South America Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Volume (K Units) by Application (2020-2031)
Figure 85. Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Radiopharmaceuticals for Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 90. Radiopharmaceuticals for Diagnosis Industry Chain Mapping
Figure 91. Regional Radiopharmaceuticals for Diagnosis Manufacturing Base Distribution (%)
Figure 92. Global Radiopharmaceuticals for Diagnosis Production Market Share by Region (2020-2031)
Figure 93. Radiopharmaceuticals for Diagnosis Production Process
Figure 94. Regional Radiopharmaceuticals for Diagnosis Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232